CORC

在结果中检索

CORC

浏览/检索结果: 共17条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Ki67 and PR to predict sensitivity of palbociclib: A real-world study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Shao, Xi-Ying;  Shen, Xia-Bo;  Li, Guang-Liang;  Zheng, Ya-Bing;  Cao, Wen-Ming
收藏  |  浏览/下载：12/0  |  提交时间：2022/01/10
Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Shao, Xiying;  Zheng, Yabing;  Cao, Wenming;  Shen, Xiabo;  Li, Guangliang
收藏  |  浏览/下载：52/0  |  提交时间：2021/06/15
Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, invitro and in human tumor xenograft models 期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 4, 页码: 1420-1430
作者:  Long, Fei;  He, Ye;  Fu, Haoyu;  Li, Yun;  Bao, Xubin
收藏  |  浏览/下载：20/0  |  提交时间：2020/07/01
CDK4/6 inhibitor protects against myocardial cells apoptosis by inhibiting RB phosphorylation in H9c2 cells 期刊论文
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 卷号: 509, 期号: 4
作者:  Li, Jing;  Liu, Quan;  Wang, Zhenggui;  Wang, Yonggang
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05
Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models. 期刊论文
Cancer science, 2019
作者:  Fei Long;  Ye He;  Haoyu Fu;  Yun Li;  Xubin Bao
收藏  |  浏览/下载：22/0  |  提交时间：2019/12/17
Progress of CDK4/6 Inhibitor Palbociclib in the Treatment of Cancer 期刊论文
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 卷号: 18, 期号: 9, 页码: 1241-1251
作者:  Chen, Fengquan;  Liu, Chunxi;  Zhang, Jian;  Xu, Wenfang;  Zhang, Yingjie
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma 期刊论文
Journal of Experimental & Clinical Cancer Research, 2018, 卷号: Vol.37 No.1, 页码: 1-15
作者:  Cheng-Lung Hsu;  Kar-Wai Lui;  Lang-Ming Chi;  Yung-Chia Kuo;  Yin-Kai Chao
收藏  |  浏览/下载：25/0  |  提交时间：2019/12/26
Biomarker analysis from a phase 1 study of palbociclib (PAL) plus letrozole (L) as first-line treatment for ER+/HER2-advanced breast cancer (ABC) in Chinese women 期刊论文
2018, 卷号: 78, 期号: 13
作者:  Xu, Binghe;  Zhang, Qingyuan;  Li, Huiping;  Sun, Wan;  Li, Wei
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Biomarker analysis from a phase 1 study of palbociclib (PAL) plus letrozole (L) as first-line treatment for ER+/HER2-advanced breast cancer (ABC) in Chinese women 会议论文
CANCER RESEARCH, 2018-07-01
作者:  Xu, Binghe;  Zhang, Qingyuan;  Li, Huiping;  Sun, Wan;  Li, Wei
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Palbociclib plus letrozole as first-line treatment for ER-positive and HER2-negative advanced breast cancer in Chinese women: a phase 1 study 会议论文
作者:  Li, Huiping;  Zhang, Qingyuan;  Li, Wei;  Wang, Shusen;  Liao, Ning
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace